Last update 21 Nov 2024
Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms Influenza Vaccine(Split Virion), Inactivated, Quadrivalent, Influenza Vaccine（Split Virion），Inactivated，Quadrivalent, Tetravalent influenza vaccine(MDCK Cells)(Wuhan Institute of Biological Products Co., Ltd.) + [2] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (25 Feb 2020), |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)评价四价流感病毒裂解疫苗（MDCK细胞）接种于3岁及以上人群安全性的单中心、盲法、阳性疫苗和安慰剂对照的Ⅰ期临床试验
[Translation] A single-center, blinded, positive vaccine and placebo-controlled phase I clinical trial to evaluate the safety of quadrivalent influenza virus split vaccine (MDCK cells) in people aged 3 years and above
探索四价流感病毒裂解疫苗在3~8周岁儿童中接种2剂和1剂的免疫原性和安全性的自身对照临床试验
[Translation] A self-controlled clinical trial to explore the immunogenicity and safety of 2 doses and 1 dose of quadrivalent influenza virus split vaccine in children aged 3 to 8 years
A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Immunogenicity and Safety of Combined Immunization of Inactivated SARS-CoV-2 Vaccines (Vero Cell) (COVAX) (Produced in Wuhan) and 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) or Quadrivalent Inactivated Influenza Vaccine (IIV4)
100 Clinical Results associated with Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)
Login to view more data
100 Deals associated with Tetravalent influenza vaccine(Wuhan Institute of Biological Products Co., Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Influenza, Human | CN | 25 Feb 2020 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Phase 3 | CN | 09 Oct 2023 | |
| Influenza, Human | Phase 3 | CN | 09 Oct 2023 | |
| Influenza A virus infection | Phase 3 | CN | 14 May 2016 | |
| Influenza B virus infection | Phase 3 | CN | 14 May 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free